Hodgkin-limfóma: vizsgálatok itt: Ausztrália
11 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleEvaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Where
- East Melbourne
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00 - 1/2. fázisTaking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Adelaide, Box Hill, Townsville
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Macquarie University, Melbourne, Nedlands, Randwick
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1. fázisTaking peopleA Study of ARC-02 in B-cell NHL
- Where
- Clayton, Melbourne, Nedlands, Southport
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - 2. fázisTaking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Heidelberg, Kogarah, Macquarie University, Nedlands
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - 1/2. fázisTaking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Adelaide, Birtinya, Fitzroy, Nedlands, South Brisbane, Waratah
- Életkor
- 12 év and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - 1. fázisTaking peopleA Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
- Where
- Melbourne
- Életkor
- 6 év to 25 év
- People
- 10
- Run by
- Murdoch Childrens Research Institute
See details and how to joinNCT06383338 - 3. fázisTaking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Adelaide, Box Hill, Brisbane, Darwin, Liverpool, Melbourne, Saint Leonards, Sydney, Townsville
- Életkor
- 16 év to 69 év
- People
- 1042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - 2/3. fázisTaking peopleA Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
- Where
- Brisbane, Perth, Sydney
- Életkor
- Up to 25 év
- People
- 210 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00 - 2. fázisTaking peoplePembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
- Where
- Adelaide, Concord, Heidelberg, Nowra, Perth, Wollongong
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT05180097 - 1. fázisTaking peopleTagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Where
- Sydney, Westmead
- Életkor
- 1 év to 21 év
- People
- 54 worldwide
- Run by
- Therapeutic Advances in Childhood Leukemia Consortium
See details and how to joinNCT05476770